← Leaderboards
Neil J Grimsey
University Of Georgia
$547,384
Attributed
$547,384
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $220.5K · FY2022–25$250K$187.5K$125K$62.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$547,384 · 2
By mechanism
R21$403,176 · 1
R03$144,208 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Georgia
Same institution · by research overlap
- Azza B El-Remessy$1,546,650
- Rick L Tarleton$28,594,617
- Sarah Anne Hamer$790,450
- Mandi M Murph$955,737
Others in their field
Other Rising Stars on “Inhibitor”
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Michael George Natchus · Emory University$10,548,554
- John Alam · Eip Pharma, Inc.$10,411,018
- Kenneth Schultz · Trethera Corporation$8,384,949
Research focus
InhibitorMolecularG-Protein-Coupled ReceptorsInflammatory ResponseIn VitroMacrophage ActivationDermalEndotheliumImmuneInflammatoryInnovationAdaptor Signaling ProteinIn VivoAnti-Inflammatory AgentsCellsCytokineEdemaEndothelial CellsHeart DamageBlood VesselsInflammationBypassAmyloidosisNovel Therapeutics
Grant awards (4)
Atypical Pathological Signaling as a Target to Regulate Retinal Vasculopathies$182,713
R21 · FY2025 · EY · contact PI
Atypical Pathological Signaling as a Target to Regulate Retinal Vasculopathies$220,463
R21 · FY2024 · EY · contact PI
Characterization of Atypical p38 signaling in Acute Lung Injury$72,104
R03 · FY2023 · AI · contact PI
Characterization of Atypical p38 signaling in Acute Lung Injury$72,104
R03 · FY2022 · AI · contact PI